ACCELERATION OF THE THROMBIN INACTIVATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PROUROKINASE) BY THROMBOMODULIN

被引:53
作者
DEMUNK, GAW [1 ]
GROENEVELD, E [1 ]
RIJKEN, DC [1 ]
机构
[1] TNO,IVVO,GAUBIUS INST,POB 430,2300 AK LEIDEN,NETHERLANDS
关键词
FIBRINOLYSIS; THROMBOLYTIC THERAPY; ENDOTHELIAL CELLS; PROTEIN-C; FETOMODULIN;
D O I
10.1172/JCI115483
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The in vitro effects of thrombomodulin on the inactivation of single chain urokinase-type plasminogen activator (scu-PA) by thrombin were investigated by incubating scu-PA with varying concentrations of human thrombin, in both the absence and presence of soluble rabbit thrombomodulin. 50% inactivation of scu-PA occurred in 45 min at 160 ng/ml thrombin in the absence of thrombomodulin and at 4.6 ng/ml thrombin in the presence of thrombomodulin. No difference was found in either the absence or the presence of thrombomodulin between the inactivation rates of high molecular weight scu-PA, and a low molecular weight scu-PA which lacked the growth factor and kringle domains. Enzyme kinetic experiments with varying concentrations of scu-PA showed that thrombomodulin decreased the K(m) of thrombin for scu-PA from 7.8 to 0.43-mu-M and increased the k(cat) from 0.30 to 1.2 s-1, corresponding to a 70-fold increase in the second-order rate constant k(cat)/K(m). SDS-polyacrylamide gel electrophoresis showed that scu-PA was cleaved into two chains upon inactivation by thrombin, and confirmed the acceleration effect of thrombomodulin on inactivation of scu-PA. Thrombomodulin thus not only has anticoagulant properties but is also antifibrinolytic. The acceleration may imply a new mechanism for the regulation of local plasminogen activator activity on the cell surface.
引用
收藏
页码:1680 / 1684
页数:5
相关论文
共 35 条
[1]   BOLUS DOSE-RESPONSE CHARACTERISTICS OF SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR AND TISSUE PLASMINOGEN-ACTIVATOR IN A DOG-MODEL OF ARTERIAL THROMBOSIS [J].
BADYLAK, SF ;
VOYTIK, S ;
KLABUNDE, RE ;
HENKIN, J ;
LESKI, M .
THROMBOSIS RESEARCH, 1988, 52 (04) :295-312
[2]   INCREASED PLASMINOGEN ACTIVATOR (UROKINASE) IN TISSUE-CULTURE AFTER FIBRIN DEPOSITION [J].
BERNIK, MB .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (04) :823-834
[3]  
BERNIK MB, 1977, THROMB HAEMOSTASIS, V38, P136
[4]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[5]   FIBRINOLYTIC PROPERTIES OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (PRO-UROKINASE) [J].
DEMUNK, GAW ;
RIJKEN, DC .
FIBRINOLYSIS, 1990, 4 (01) :1-9
[6]  
DITTMAN WA, 1990, BLOOD, V75, P329
[7]   INDUCTION OF MARKED THROMBIN ACTIVITY BY PHARMACOLOGIC CONCENTRATIONS OF PLASMINOGEN ACTIVATORS IN NONANTICOAGULATED WHOLE-BLOOD [J].
EISENBERG, PR ;
MILETICH, JP .
THROMBOSIS RESEARCH, 1989, 55 (05) :635-643
[8]  
ESMON CT, 1982, J BIOL CHEM, V257, P7944
[9]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743
[10]   PROTEIN-C ACTIVATION [J].
ESMON, CT ;
ESMON, NL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1984, 10 (02) :122-130